Literature DB >> 8326493

Interaction of incontinentia pigmenti and factor VIII mutations in a female with biased X inactivation, resulting in haemophilia.

R Coleman1, S A Genet, J I Harper, A O Wilkie.   

Abstract

We report a female infant born to a mother with incontinentia pigmenti (IP) and a father with haemophilia A, who manifests both disorders. Analysis of peripheral blood DNA from the infant, her mother, and two female relatives with IP showed a highly skewed pattern of X inactivation. Random patterns were observed in the infant's two sisters, who do not have IP and have normal carrier activity of factor VIII. Preferential inactivation of the X chromosome bearing the IP mutation, probably by negative selection, appears to have unmasked the factor VIII mutation on the infant's other X chromosome. This illustrates an unusual mechanism for the manifestation of an X linked disease in a heterozygous female.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8326493      PMCID: PMC1016424          DOI: 10.1136/jmg.30.6.497

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  21 in total

1.  X inactivation as a mechanism of selection against lethal alleles: further investigation of incontinentia pigmenti and X linked lymphoproliferative disease.

Authors:  A Harris; J Collins; D Vetrie; C Cole; M Bobrow
Journal:  J Med Genet       Date:  1992-09       Impact factor: 6.318

2.  Haemophilia treatment in the United Kingdom from 1969 to 1974.

Authors:  R Biggs
Journal:  Br J Haematol       Date:  1977-04       Impact factor: 6.998

3.  Distribution of factor VIII mRNA and antigen in human liver and other tissues.

Authors:  K L Wion; D Kelly; J A Summerfield; E G Tuddenham; R M Lawn
Journal:  Nature       Date:  1985 Oct 24-30       Impact factor: 49.962

4.  Characterization of the human factor VIII gene.

Authors:  J Gitschier; W I Wood; T M Goralka; K L Wion; E Y Chen; D H Eaton; G A Vehar; D J Capon; R M Lawn
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

5.  Factor VIII related antigen: an improved enzyme immunoassay.

Authors:  P E Short; C E Williams; A M Picken; F G Hill
Journal:  Med Lab Sci       Date:  1982-10

6.  Two cases of X/autosome translocation in females with incontinentia pigmenti.

Authors:  S V Hodgson; B Neville; R W Jones; C Fear; M Bobrow
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

7.  X inactivation patterns in two syndromes with probable X-linked dominant, male lethal inheritance.

Authors:  P Wieacker; J Zimmer; H H Ropers
Journal:  Clin Genet       Date:  1985-09       Impact factor: 4.438

8.  Genetic screening for hemophilia A (classic hemophilia) with a polymorphic DNA probe.

Authors:  I Oberle; G Camerino; R Heilig; L Grunebaum; J P Cazenave; C Crapanzano; P M Mannucci; J L Mandel
Journal:  N Engl J Med       Date:  1985-03-14       Impact factor: 91.245

9.  Detection of factor VIII/coagulant antigen in human liver tissue.

Authors:  H V Stel; T H van der Kwast; E C Veerman
Journal:  Nature       Date:  1983 Jun 9-15       Impact factor: 49.962

10.  Detection of carriers of classic hemophilia using an immunologic assay for antihemophilic factor (factor 8().

Authors:  T S Zimmerman; O D Ratnoff; A S Littell
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

View more
  4 in total

1.  From genotype to phenotype: genetics and medical practice in the new millennium.

Authors:  D Weatherall
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-12-29       Impact factor: 6.237

2.  Gonadal mosaicism for incontinentia pigmenti in a healthy male.

Authors:  T T Kirchman; M L Levy; R A Lewis; M H Kanzler; D L Nelson; A E Scheuerle
Journal:  J Med Genet       Date:  1995-11       Impact factor: 6.318

Review 3.  Genetic causes of haemophilia in women and girls.

Authors:  Connie H Miller; Christopher J Bean
Journal:  Haemophilia       Date:  2020-12-13       Impact factor: 4.263

4.  Mutation spectrum of 122 hemophilia A families from Taiwanese population by LD-PCR, DHPLC, multiplex PCR and evaluating the clinical application of HRM.

Authors:  Shin-Yu Lin; Yi-Ning Su; Chia-Cheng Hung; Woei Tsay; Shyh-Shin Chiou; Chieh-Ting Chang; Hong-Nerng Ho; Chien-Nan Lee
Journal:  BMC Med Genet       Date:  2008-06-20       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.